Mark Fletcher, VP & General Counsel at GENEREX BIOTECHNOLOGY CORP (GNBT), sold 228,342 shares at $1.14 ($263K) on 2008-04-18, disclosed to the SEC on 2008-04-21.
Open-market sale of $263k GNBT by VP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.14 | 100,000 | $114K | 43.4% |
| 2 | $1.16 | 128,342 | $149K | 56.6% |
| Total | $1.15 avg | 228,342 | $263K | 100% |
| Filing → |
| GNBT | BUY | 2009-11-16 | $5K | — | Filing → |
| GNBT | BUY | 2009-01-12 | $4K | — | Filing → |
| GNBT | BUY | 2008-11-03 | $9K | — | Filing → |